Finance

Lists
Why is APMD up 2.88%?
Dive Deeper
APMD:NASDAQ
Apnimed Inc
$22.54
+2.88%
(+0.63) 1D
$22.54
0.00% (0.00)
After hours
Closed: Oct 1, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for APMD...
Open
$21.96
High
$24.50
Low
$21.96
Mkt. cap
938.36M
Avg. vol.
514.31K
Volume
39.00
52-wk high
$35.29
52-wk low
$16.12
EPS
-$0.80
No. of employees
81
Open
$21.96
High
$24.50
Low
$21.96
Mkt. cap
938.36M
Avg. vol.
514.31K
Volume
39.00
52-wk high
$35.29
52-wk low
$16.12
EPS
-$0.80
No. of employees
81
News stories
From web sources and news partners
About Apnimed Inc
CEO-
Employees81
Founded2017
Headquarters-
SectorPharmaceutical industry
Analyst ratings
Based on 4 analysts giving stock ratings to APMD in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for APMD in the last 3 months.
Highest
Current $22.54
$60.00 (+166.19%)
Average
$50.33 (+123.29%)
Lowest
$41.00 (+81.90%)
Analyst
Recommendation
Action
Price target
Projected
Date
Francois Brisebois
LifeSci Capital
Buy
Maintained
$50.00
+121.8%
09/09/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Initiated
$60.00
+166.2%
08/25/2026
Umer Raffat
Evercore ISI
Buy
Initiated
-
-
08/25/2026
Jason Gerberry
Bank of America Securities
Buy
Initiated
$41.00
+81.9%
08/25/2026
Last report
Sep 8, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.42 / -$0.34
-22.47%miss
Revenue / Est. (USD)
12.08M / 0.00
+∞%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Mar 2026
Jun 2026
Revenue
3.13M
17.11M
84.81M
12.08M
Cost of goods sold
1.32M
1.72M
2.16M
1.21M
Cost of revenue
1.32M
1.72M
2.16M
1.21M
Research and development expenses
23.46M
15.97M
8.10M
9.90M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.47M
5.35M
6.51M
12.67M
Operating expense
28.93M
21.32M
14.61M
22.57M
Total operating expenses
30.24M
23.05M
16.77M
23.78M
Operating income
-27.11M
-5.94M
68.04M
-11.70M
Other non operating income
-
-
-
54.99M
EBT including unusual items
-26.68M
-5.63M
70.37M
126.11M
EBT excluding unusual items
-26.68M
-5.63M
68.26M
126.79M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-28.65M
-69.47M
67.72M
125.94M
Net profit margin
-914.92%
-406.04%
79.84%
1,042.51%
Earnings per share
-
-
-
-0.42
Interest and investment income
431.00K
309.00K
218.00K
970.00K
Interest expense
-
-
-
-2.84M
Net interest expenses
431.00K
309.00K
218.00K
-1.88M
Depreciation and amortization charges
-
-
-
-
EBITDA
-27.10M
-5.93M
68.05M
-11.70M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps